Company intelligence / Profile preview
Pathfinder Therapeutics
Nashville, Tennessee, United Statesprnewswire.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
The original Pathfinder Therapeutics developed FDA-cleared image-guided surgical navigation systems for liver surgery. The company was sold to Analogic in 2014. A new company with the same name was founded in 2024, focusing on RNA-based cancer therapies.
- Therapeutic areas
- Oncology
- Modalities
- RNA technologyImage-guided surgical navigation
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Pathfinder Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pathfinder Therapeutics.